Botulax 300
is the latest botulinum toxin type A product from the Hugel team. It comes as a lyophilized white powder for injection, contained in a colorless transparent vial. When the diluent (physiological saline) is added, it should dissolve into a colorless transparent liquid.
It is used for the temporary improvement of moderate to severe glabellar wrinkles associated with the activity of the corrugator and/or procerus muscles in adults aged 18 to 65. Additionally, it can be used to treat benign essential blepharospasm in adult patients aged 18 and older.
In addition to obtaining KFDA(Korea Food and Drug Administration) certification in 2016, Botulax (Called Letybo in US) has received United States (U.S.) Food and Drug Administration (FDA) approval in 2024.
What benefits can you expect from Botulax 300U?
- Effective Wrinkle Reduction: Botulax 300U is effective in temporarily reducing the appearance of moderate to severe glabellar wrinkles, leading to a smoother and more youthful look.
- Treatment of Blepharospasm: It is useful in treating benign essential blepharospasm, helping to relieve involuntary eyelid spasms and improve patients’ quality of life.
- Precision and Consistency: The product’s formulation allows for precise dosing and consistent results, ensuring predictable outcomes for both cosmetic and therapeutic applications.
- Minimal Downtime: Procedures involving Botulax 300U typically have minimal recovery time, allowing patients to resume their daily activities shortly after treatment.
- Non-Surgical Option: As a non-surgical treatment, Botulax 300U offers a less invasive alternative to surgery for wrinkle reduction and muscle spasm relief, with fewer risks and complications.
- Safe and Well-Tolerated: When administered by a qualified professional, Botulax 300U is generally safe and well-tolerated, with a well-established safety profile.
